782
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

First and recurrent events after percutaneous coronary intervention: implications for survival analyses

, , , , , ORCID Icon, , , , , , & show all
Pages 299-304 | Received 31 Jul 2018, Accepted 12 Jul 2019, Published online: 25 Jul 2019

References

  • Goldberg R, Gore JM, Barton B, et al. Individual and composite study endpoints: separating the wheat from the chaff. Am J Med. 2014;127:379–384.
  • Glynn RJ, Buring JE. Ways of measuring rates of recurrent events. BMJ. 1996;312:364.
  • Andersen PK, Gill RD. Cox’s regression model for counting processes: a large sample study. Ann. Statist. 1982;10:1100–1120.
  • Wei LJ, Lin DY, Weissfeld L. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Stat Assoc. 1989;84:1065–1073.
  • Prentice RL, Williams BJ, Peterson AV. On the regression analysis of multivariate failure time data. Biometrika 1981;68:373–379.
  • Therneau TM, Grambsch P. Modeling survival data. extending the cox model. New York (NY): Springer; 2000.
  • Amorim LD, Cai J. Modelling recurrent events: a tutorial for analysis in epidemiology. Int J Epidemiol. 2015;44:324–333.
  • Rondeau V, Mathoulin-Pelissier S, Jacqmin-Gadda H, et al. Joint frailty models for recurring events and death using maximum penalized likelihood estimation: application on cancer events. Biostatistics. 2007;8:708–721.
  • Rogers JK, Yaroshinsky A, Pocock SJ, et al. Analysis of recurrent events with an associated informative dropout time: application of the joint frailty model. Stat Med. 2016;35:2195–2205.
  • DWHC Foundation [Internet]. Irwing (TX): DWHC; Available from: https://dfwhcfoundation.org/data/. Accessed 05 January 2018.
  • Hicks KA, Tcheng JE, Bozkurt B, et al. 2014 ACC/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials: a report of the American College of Cardiology/American Heart Association Task Force on clinical data standards (writing committee to develop cardiovascular endpoints data standards). J Nucl Cardiol. 2015;22:1041–1144.
  • National Technical Informatioin Service [Internet]. Alexandria (VA): NTIS; Available from: https://classic.ntis.gov/products/ssa-dmf/#. Accessed 05 January 2018.
  • Gloria C, Lisa S, Steven W, et al. Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review. BMJ. 2010;341:c3920.
  • Kip KE, Hollabaugh K, Marroquin OC, et al. The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention. J Am Coll Cardiol. 2008;51:701–707.
  • Parving HH, Brenner BM, McMurray JJ, et al. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med. 2012;367:2204–2213.
  • Mahaffey KW, Neal B, Perkovic V, et al. Canagliflozin for primary and secondary prevention of cardiovascular events: results from the CANVAS program (Canagliflozin Cardiovascular Assessment Study). Circulation. 2018;137:323–334.
  • Rogers JK, Kielhorn A, Borer JS, et al. Effect of ivabradine on numbers needed to treat for the prevention of recurrent hospitalizations in heart failure patients. Curr Med Res Opin. 2015;31:1903–1909.
  • Rogers JK, Pocock SJ, McMurray JJ, et al. Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved. Eur J Heart Fail. 2014;16:33–40.
  • Anker SD, McMurray JJ. Time to move on from ‘time-to-first’: should all events be included in the analysis of clinical trials? Eur Heart J. 2012;33:2764–2765.
  • Rondeau V. Statistical models for recurrent events and death: application to cancer events. Math Comput Model. 2010;52:949–955.
  • Rogers JK, McMurray JJV, Pocock SJ, et al. Eplerenone in patients with systolic heart failure and mild symptoms: analysis of repeat hospitalizations. Circulation. 2012;126:2317–2323.
  • Abraham WT, Adamson PB, Bourge RC, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011;377:658–666.
  • Cleland JG, Louis AA, Rigby AS, et al. Noninvasive home telemonitoring for patients with heart failure at high risk of re- current admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. J Am Coll Cardiol. 2005;45:1654–1664.
  • Król A, Mauguen A, Mazroui Y, et al. Tutorial in joint modeling and prediction: a statistical software for correlated longitudinal outcomes, recurrent events and a terminal event. J Stat Soft. 2017;81:1–52.
  • Abdul-Aziz AA, Hayward RA, Aaronson KD, et al. Association between medicare hospital readmission penalties and 30-day combined excess readmission and mortality. JAMA Cardiol. 2017;2:200–203.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.